Dade Behring Inc. (NASDAQ:DADE), the world's largest company solely dedicated to clinical diagnostics, today announced the introduction of several enhancements to the Company's scalable automation solution, the StreamLAB� Analytical Workcell. The new enhancements will assure the opportunity for clinical laboratories of all types and sizes to install automation in a smaller space and also take advantage of new capabilities such as connectivity to a new middleware data management solution. "These enhancements reflect our focus on developing the future of clinical laboratory automation technology," said Jim-Reid Anderson, Chairman, President and CEO, Dade Behring. "We remain committed to investing in new capabilities for our customers, allowing them to take advantage of today's fast-paced changes in technology to create efficiencies in their laboratory." The several enhancements to the StreamLAB� Analytical Workcell include: A 90 degree track-turn configuration so it fits in smaller spaces. Flexibility with the configuration allows a laboratory to install the system in corners and around columns, minimizing renovation costs commonly incurred when installing automation and additional analyzers. Connectivity to the EasyLink� Informatics System, a middleware software program that improves data management capabilities between the StreamLAB� Analytical Workcell, multiple diagnostic systems and a laboratory information system (LIS). A tube sealer that applies a seal to patient samples. This allows for hands-off sample management, accommodates a variety of tube sizes simultaneously, protects the integrity of patient samples and helps minimize laboratory personnel's exposure to biohazards. The StreamLAB� Integrated Workcell is designed to evolve with a clinical laboratory's changing needs. It is a scalable system that provides for workstation consolidation while automating pre- and post-analytical functions. The StreamLAB� Integrated Workcell has the ability to connect to multiple Dimension� Integrated Chemistry Systems, the Sysmex� CA-7000 high-volume coagulation analyzer and also has an open connectivity feature allowing customers to connect it to other selected manufacturers' systems. About Dade Behring With 2006 revenue of more than $1.7 billion, Dade Behring is the world's largest company solely dedicated to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com. This press release may contain "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward statements include information regarding the intent, belief or current expectation of the company and members of its senior management team, including, without limitation, expectations regarding prospective performance and opportunities and the outlook for the company's businesses, performance, opportunities and regulatory approval. In addition, the company is in the process of a major new product launch, which involves risks and uncertainties regarding product performance, costs of introduction and support, and customer acceptance. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by the company.
Dade Behring (NASDAQ:DADE)
過去 株価チャート
から 10 2024 まで 11 2024 Dade Behringのチャートをもっと見るにはこちらをクリック
Dade Behring (NASDAQ:DADE)
過去 株価チャート
から 11 2023 まで 11 2024 Dade Behringのチャートをもっと見るにはこちらをクリック